4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-22-045488
President and CEO bought 68,000 shares at $1.50 ($102,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror President and CEO | 2022-04-11 | Purchase | +68,000 | $1.50 | $102,000 | 68,000 | D |
| Open-market purchases · 68,000 sh · avg $1.50 · $102,000 | |||||||
Loading xslF345X03/tm2212654-1_4seq1.xml…